08:01 AM EDT, 09/18/2024 (MT Newswires) -- GSK (GSK) said Wednesday that the phase 3 trial evaluating the co-administration of AREXVY with SHINGRIX in adults aged 50 years and older met its primary endpoint. The data showed a non-inferior immune response when both vaccines were co-administered compared with a separate administration, the company said. The company further said the co-administration...

08:03 AM EDT, 09/18/2024 (MT Newswires) -- Organon (OGN) said Wednesday it has agreed to acquire Roivant's (ROIV) Dermavant, including its flagship dermatological cream Vtama, for a total consideration of $1.2 billion. Under the deal, Organon will pay $175 million upfront with $75 million as milestone payment after the US Food and Drug Administration approves Vtama's application for treatment of...

Sept 18 (Reuters) - Healthcare company Organon said on Wednesday it has agreed to acquire skin therapy developer Dermavant, a unit of Roivant, for up to $1.2 billion. Organon will make an upfront payment of $175 million, as well as milestone payments of $75 million and up to $950 million upon achievement of certain commercial milestones. Dermavant's VTAMA psoriasis cream...

07:52 AM EDT, 09/18/2024 (MT Newswires) -- On the Canadian docket Wednesday at 1:30 p.m. ET, Bank of Montreal (BMO) noted that the Summary of Deliberations from the Bank of Canada's Sept. 4 policy meeting, which saw a third consecutive 25 bp rate cut, will be scoured for any clues on what it would take to prompt more aggressive easing....